Catheters sold: 790 (+15% Y/Y).
Procedures performed: ~750 (+14% Y/Y but -13% Q/Q).
YTD procedure growth: ~24%.
"Hospitals continue to be challenged to manage costs and to make capital spending decisions carefully," CEO Bruce Barclay says.
FY13 outlook: Commercialization of 14-17 systems (unchanged), total estimated procedures of 3,200-3,400 (unchanged). (PR)